الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 166 |  |  |
| | | from | 166 | | |
Abstract
The prevalence of hepatitis C virus (HCV) infection varies throughout the world, with the highest number of infections reported in Egypt. The prevalence of antibodies against HCV in various regions ranging from 6% to 28% (mean, 22%). An estimated 70% to 85% of infected patients are likely to develop chronic hepatitis, and up to 30% of these cases might progress to cirrhosis. As it was observed that prevalence rates of a variety of psychiatric disorders were higher in patients with hepatitis C than in the general population. Which negatively affect patients’ functional health, ability to work, quality of life and well being. So one of the most important thinking is HCV and interferon related psychiatric symptoms as well as recommendations for their clinical management. Beside that, neuropsychiatric symptoms have been reported in association with both the acute and chronic stages of hepatitis C.